Aclacinomycin inhibits suppressor cells in vivo and in vitro. 1984

S Orbach-Arbouys, and C E Andrade-Mena, and M Berardet, and G Mathe

After the intraperitoneal injection of aclacinomycin into mice, a variety of immune responses are increased. The responsible mechanism is the elimination of suppressor cells since aclacinomycin inhibits the expression of tolerance to SRBC in mice and diminishes the capacity of spleen cells from SRBC-tolerant mice to inhibit the response of normal animals upon adoptive transfer, either when injected to the donor tolerant mice before the cell transfer or when in vitro incubated with the tolerant cells for 1 hour: both treatments had eliminated suppressor cells from the tolerant spleen cell population.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009279 Naphthacenes Polyacenes with four ortho-fused benzene rings in a straight linear arrangement. This group is best known for the subclass called TETRACYCLINES. Tetracenes,Benz(b)Anthracenes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D000921 Antibody-Producing Cells Cells of the lymphoid series that can react with antigen to produce specific cell products called antibodies. Various cell subpopulations, often B-lymphocytes, can be defined, based on the different classes of immunoglobulins that they synthesize. Antibody-Producing Cell,Antibody-Secreting Cell,Antibody-Secreting Cells,Immunoglobulin-Producing Cells,Immunoglobulin-Secreting Cells,Antibody Producing Cell,Antibody Producing Cells,Antibody Secreting Cell,Antibody Secreting Cells,Cell, Antibody-Producing,Cell, Antibody-Secreting,Cell, Immunoglobulin-Producing,Cell, Immunoglobulin-Secreting,Cells, Antibody-Producing,Cells, Antibody-Secreting,Cells, Immunoglobulin-Producing,Cells, Immunoglobulin-Secreting,Immunoglobulin Producing Cells,Immunoglobulin Secreting Cells,Immunoglobulin-Producing Cell,Immunoglobulin-Secreting Cell
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

S Orbach-Arbouys, and C E Andrade-Mena, and M Berardet, and G Mathe
September 2017, Immunotherapy,
S Orbach-Arbouys, and C E Andrade-Mena, and M Berardet, and G Mathe
February 1999, European journal of immunology,
S Orbach-Arbouys, and C E Andrade-Mena, and M Berardet, and G Mathe
May 1988, Yao xue xue bao = Acta pharmaceutica Sinica,
S Orbach-Arbouys, and C E Andrade-Mena, and M Berardet, and G Mathe
January 2001, Oncogene,
S Orbach-Arbouys, and C E Andrade-Mena, and M Berardet, and G Mathe
March 1981, The Journal of antibiotics,
S Orbach-Arbouys, and C E Andrade-Mena, and M Berardet, and G Mathe
October 1984, Journal of immunology (Baltimore, Md. : 1950),
S Orbach-Arbouys, and C E Andrade-Mena, and M Berardet, and G Mathe
January 1995, Yao xue xue bao = Acta pharmaceutica Sinica,
S Orbach-Arbouys, and C E Andrade-Mena, and M Berardet, and G Mathe
June 2013, Biochemical and biophysical research communications,
S Orbach-Arbouys, and C E Andrade-Mena, and M Berardet, and G Mathe
October 2012, Apoptosis : an international journal on programmed cell death,
S Orbach-Arbouys, and C E Andrade-Mena, and M Berardet, and G Mathe
January 2007, In vivo (Athens, Greece),
Copied contents to your clipboard!